Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?

被引:21
作者
Bakker, SJL [1 ]
Gansevoort, RT [1 ]
Stuveling, EM [1 ]
Gans, ROB [1 ]
de Zeeuw, D [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Internal Med, NL-9713 GZ Groningen, Netherlands
关键词
D O I
10.1007/s11906-005-0075-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk. The first is closely related to systemic and vascular low-grade inflammation, the latter is considered to be a marker of endothelial dysfunction. Because of these properties, one might presume them to be closely interrelated. In this article, we review the available evidence concerning the relationships of CRP and urinary albumin excretion, with each other and with other cardiovascular risk markers might be present in the cardiovascular risk estimation formula of the near future. The reasons that this formula might or should CRP and urinary albumin and the metabolic syndrome are discussed.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 59 条
[31]   N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults [J].
Kistorp, C ;
Raymond, I ;
Pedersen, F ;
Gustafsson, F ;
Faber, J ;
Hildebrandt, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1609-1616
[32]   C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].
Koenig, W ;
Sund, M ;
Fröhlich, M ;
Fischer, HG ;
Löwel, H ;
Döring, A ;
Hutchinson, WL ;
Pepys, MB .
CIRCULATION, 1999, 99 (02) :237-242
[33]   Retention of albumin in the circulation is governed by saturable renal cell-mediated processes [J].
Koltun, M ;
Comper, WD .
MICROCIRCULATION, 2004, 11 (04) :351-360
[34]   Comparis on of the effects of Ramipril versus Telmisartan in reducing serum levels of high-sensitivity, C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus [J].
Koulouris, S ;
Symeonides, P ;
Triantafyllou, K ;
Ioannidis, G ;
Karabinos, I ;
Katostaras, T ;
El-Ali, M ;
Theodoridis, T ;
Vratsista, E ;
Thalassinos, N ;
Kokkinou, V ;
Nanas, I ;
Stamatelopoulos, S ;
Toutouzas, P .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11) :1386-1388
[35]  
Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963
[36]   Poor predictive value of high-sensitivity C-reactive protein indicates need for reassessment [J].
Levinson, SS ;
Miller, JJ ;
Elin, RJ .
CLINICAL CHEMISTRY, 2004, 50 (10) :1733-1735
[38]   MICROALBUMINURIA PRECEDES THE DEVELOPMENT OF NIDDM [J].
MYKKANEN, L ;
HAFFNER, SM ;
KUUSISTO, J ;
PYORALA, K ;
LAAKSO, M .
DIABETES, 1994, 43 (04) :552-557
[39]   Association between serum C-reactive protein levels and microalbuminuria: A population-based cross-sectional study in northern Iwate, Japan [J].
Nakamura, M ;
Onoda, T ;
Itai, K ;
Ohsawa, M ;
Satou, K ;
Sakai, T ;
Segawa, T ;
Sasaki, J ;
Tonari, Y ;
Hiramori, K ;
Okayama, A .
INTERNAL MEDICINE, 2004, 43 (10) :919-925
[40]   CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers [J].
Ohsawa, M ;
Okayama, A ;
Nakamura, M ;
Onoda, T ;
Kato, K ;
Itai, K ;
Yoshida, Y ;
Ogawa, A ;
Kawamura, K ;
Hiramori, K .
PREVENTIVE MEDICINE, 2005, 41 (02) :651-656